For example, IL-25 was added to IL-4 and IL-13 because this cytokine can act on both immune cells (85) and keratinocytes, where it can reduce expression of FLG (19), explaining thereby the systematic link observed between inflammation and barrier disruption in AD lesions (22, 86). Here, FLG is linked to Alzheimer disease.